Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-News: ENCAVIS AG placed successfully Green Promissory Note Bond in the amount of EUR 210 million for further growth projects: https://upload.wikimedia.org/wikipedia/commons/thumb/4/44/Encavis_logo.svg/1024px-Encavis_logo.svg.png
EQS-News: ENCAVIS AG placed successfully Green Promissory Note Bond in the amount of EUR 210 million for further growth projects
EQS-News: ENCAVIS AG placed successfully Green Promissory Note Bond in the amount of EUR 210 million for further growth projects
EQS-Adhoc: Sixt SE: Announcement of the dividend proposal for financial year 2022, forecast for financial year 2023 and trend for the first quarter of 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24124/362px-Sixt-Logo.svg.png
EQS-Adhoc: Sixt SE: Announcement of the dividend proposal for financial year 2022, forecast for financial year 2023 and trend for the first quarter of 2023
EQS-Adhoc: Sixt SE: Announcement of the dividend proposal for financial year 2022, forecast for financial year 2023 and trend for the first quarter of 2023
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-Adhoc: Siltronic resolves upon forecast of financial year 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png
EQS-Adhoc: Siltronic resolves upon forecast of financial year 2023
EQS-Adhoc: Siltronic resolves upon forecast of financial year 2023
EQS-Adhoc: Siltronic resolves upon forecast of financial year 2023: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24068/Siltronic_Logo.svg.png
EQS-Adhoc: Siltronic resolves upon forecast of financial year 2023
EQS-Adhoc: Siltronic resolves upon forecast of financial year 2023
EQS-News: 1&1 requests the Federal Cartel Office [Bundeskartellamt] to review the hindrance of the construction of the fourth German mobile network. Slight delays in network launch possible. : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png
EQS-News: 1&1 requests the Federal Cartel Office [Bundeskartellamt] to review the hindrance of the construction of the fourth German mobile network. Slight delays in network launch possible.
EQS-News: 1&1 requests the Federal Cartel Office [Bundeskartellamt] to review the hindrance of the construction of the fourth German mobile network. Slight delays in network launch possible.
EQS-News: 1&1 requests the Federal Cartel Office [Bundeskartellamt] to review the hindrance of the construction of the fourth German mobile network. Slight delays in network launch possible. : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24057/Drillisch_AG_Logo.svg.png
EQS-News: 1&1 requests the Federal Cartel Office [Bundeskartellamt] to review the hindrance of the construction of the fourth German mobile network. Slight delays in network launch possible.
EQS-News: 1&1 requests the Federal Cartel Office [Bundeskartellamt] to review the hindrance of the construction of the fourth German mobile network. Slight delays in network launch possible.
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-Adhoc: Fielmann AG: Preliminary Figures for FY2022/Dividend : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23710/Fielmann-Logo.svg.png
EQS-Adhoc: Fielmann AG: Preliminary Figures for FY2022/Dividend
EQS-Adhoc: Fielmann AG: Preliminary Figures for FY2022/Dividend
EQS-News: AUTO1 Group SE: AUTO1 Group reports record results in 2022:
EQS-News: AUTO1 Group SE: AUTO1 Group reports record results in 2022
EQS-News: AUTO1 Group SE: AUTO1 Group reports record results in 2022
EQS-News: Krones AG: Krones verbesserte 2022 alle wesentlichen Finanzkennzahlen und prognostiziert für 2023 weiteres Umsatz- und Ergebniswachstum : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23725/Krones_Logo.svg.png
EQS-News: Krones AG: Krones verbesserte 2022 alle wesentlichen Finanzkennzahlen und prognostiziert für 2023 weiteres Umsatz- und Ergebniswachstum
EQS-News: Krones AG: Krones verbesserte 2022 alle wesentlichen Finanzkennzahlen und prognostiziert für 2023 weiteres Umsatz- und Ergebniswachstum
EQS-News: freenet AG: freenet continues to impress in financial year 2022 and proposes a dividend of 1.68 euros per share: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24058/375px-Freenet_AG_Logo.svg.png
EQS-News: freenet AG: freenet continues to impress in financial year 2022 and proposes a dividend of 1.68 euros per share
EQS-News: freenet AG: freenet continues to impress in financial year 2022 and proposes a dividend of 1.68 euros per share
EQS-News: freenet AG: freenet continues to impress in financial year 2022 and proposes a dividend of 1.68 euros per share: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24058/375px-Freenet_AG_Logo.svg.png
EQS-News: freenet AG: freenet continues to impress in financial year 2022 and proposes a dividend of 1.68 euros per share
EQS-News: freenet AG: freenet continues to impress in financial year 2022 and proposes a dividend of 1.68 euros per share
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
EQS-News: KION Group building a new highly automated Spare Parts Distribution Center in Germany : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23724/Kion_Group_logo.svg.png
EQS-News: KION Group building a new highly automated Spare Parts Distribution Center in Germany
EQS-News: KION Group building a new highly automated Spare Parts Distribution Center in Germany
EQS-News: Confident FY23 outlook building on strong growth momentum & successful completion of ‘Investment-for-Growth’ programme: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24073/Telefonica_Logo.svg.png
EQS-News: Confident FY23 outlook building on strong growth momentum & successful completion of ‘Investment-for-Growth’ programme
EQS-News: Confident FY23 outlook building on strong growth momentum & successful completion of ‘Investment-for-Growth’ programme
EQS-News: Confident FY23 outlook building on strong growth momentum & successful completion of ‘Investment-for-Growth’ programme: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24073/Telefonica_Logo.svg.png
EQS-News: Confident FY23 outlook building on strong growth momentum & successful completion of ‘Investment-for-Growth’ programme
EQS-News: Confident FY23 outlook building on strong growth momentum & successful completion of ‘Investment-for-Growth’ programme
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
TUI AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution: https://upload.wikimedia.org/wikipedia/commons/1/1c/TUI_Logo_neu.png
TUI AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
TUI AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS-News: GRENKE: Dr Sebastian Hirsch takes over from Michael Bücker as CEO : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg
EQS-News: GRENKE: Dr Sebastian Hirsch takes over from Michael Bücker as CEO
EQS-News: GRENKE: Dr Sebastian Hirsch takes over from Michael Bücker as CEO
EQS-Adhoc: GRENKE: Dr Sebastian Hirsch takes over from Michael Bücker as CEO: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg
EQS-Adhoc: GRENKE: Dr Sebastian Hirsch takes over from Michael Bücker as CEO
EQS-Adhoc: GRENKE: Dr Sebastian Hirsch takes over from Michael Bücker as CEO
TUI AG: Results of Annual General Meeting, Capital Reduction and Share Consolidation: https://upload.wikimedia.org/wikipedia/commons/1/1c/TUI_Logo_neu.png
TUI AG: Results of Annual General Meeting, Capital Reduction and Share Consolidation
TUI AG: Results of Annual General Meeting, Capital Reduction and Share Consolidation